NLRP3 and Sepsis: Reduced NLRP3 inflammasome-mediated IL-1β release and decreased caspase-3 concentrations, thus lead to inhibited apoptosis and pyroptosis alleviated pulmonary pathological damage and improved the survival rate of the sepsis mice via the MAPK/NF-κB/NLRP3 pathway (19).